Animal serum-free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BM
Tài liệu tham khảo
Fibbe, 2003, Mesenchymal stem cells and hematopoietic stem cell transplantation, Ann NY Acad Sci, 996, 235, 10.1111/j.1749-6632.2003.tb03252.x
Pittenger, 1999, Multilineage potential of adult human mesenchymal stem cells, Science, 284, 143, 10.1126/science.284.5411.143
Krampera, 2003, Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide, Blood, 101, 3722, 10.1182/blood-2002-07-2104
Horwitz, 2002, Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone, Proc Natl Acad Sci USA, 99, 8932, 10.1073/pnas.132252399
Le Blanc, 2005, Fetal mesenchymal stem-cell engraftment in bone after in utero transplantation in a patient with severe osteogenesis imperfecta, Transplantation, 79, 1607, 10.1097/01.TP.0000159029.48678.93
Kawada, 2004, Nonhematopoietic mesenchymal stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarction, Blood, 104, 3581, 10.1182/blood-2004-04-1488
Satake, 2004, Migration of mesenchymal stem cells through cerebrospinal fluid into injured spinal cord tissue, Spine, 29, 1971, 10.1097/01.brs.0000138273.02820.0a
Koc, 2002, Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH), Bone Marrow Transplant, 30, 215, 10.1038/sj.bmt.1703650
Le Blanc, 2004, Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells, Lancet, 363, 1439, 10.1016/S0140-6736(04)16104-7
Lazarus, 2005, Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients, Biol Blood Marrow Transplant, 11, 389, 10.1016/j.bbmt.2005.02.001
Zappia, 2005, Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy, Blood, 106, 1755, 10.1182/blood-2005-04-1496
Jorgensen, 2003, Engineering mesenchymal stem cells for immunotherapy, Gene Ther, 10, 928, 10.1038/sj.gt.3302019
Koc, 1999, Bone marrow-derived mesenchymal stem cells remain host-derived despite successful hematopoietic engraftment after allogeneic transplantation in patients with lysosomal and peroxisomal storage diseases, Exp Hematol, 27, 1675, 10.1016/S0301-472X(99)00101-0
Hongeng, 2001, Host origin of marrow mesenchymal stem cells following allogeneic cord-blood stem-cell transplantation, Int J Hematol, 74, 235, 10.1007/BF02982012
Rieger, 2005, Mesenchymal stem cells remain of host origin even a long time after allogeneic peripheral blood stem cell or bone marrow transplantation, Exp Hematol, 33, 605, 10.1016/j.exphem.2005.02.004
Kim, 2004, Cotransplantation of third-party mesenchymal stromal cells can alleviate single-donor predominance and increase engraftment from double cord transplantation, Blood, 103, 1941, 10.1182/blood-2003-05-1601
Noort, 2002, Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34(+) cells in NOD/SCID mice, Exp Hematol, 30, 870, 10.1016/S0301-472X(02)00820-2
Burns, 2005, Tumorigenic heterogeneity in cancer stem cells evolved from long-term cultures of telomerase-immortalized human mesenchymal stem cells, Cancer Res, 65, 3126, 10.1158/0008-5472.CAN-04-2218
Wang, 2005, Outgrowth of a transformed cell population derived from normal human BM mesenchymal stem cell culture, Cytotherapy, 7, 509, 10.1080/14653240500363216
Kuznetsov, 2000, Effect of serum on human bone marrow stromal cells: ex vivo expansion and in vivo bone formation, Transplantation, 70, 1780, 10.1097/00007890-200012270-00018
Spees, 2004, Internalized antigens must be removed to prepare hypoimmunogenic mesenchymal stem cells for cell and gene therapy, Mol Ther, 9, 747, 10.1016/j.ymthe.2004.02.012
Shahdadfar, 2005, In vitro expansion of human mesenchymal stem cells: choice of serum is a determinant of cell proliferation, differentiation, gene expression, and transcriptome stability, Stem Cells, 23, 1357, 10.1634/stemcells.2005-0094
Deans, 2000, Mesenchymal stem cells: biology and potential clinical uses, Exp Hematol, 28, 875, 10.1016/S0301-472X(00)00482-3
Horwitz, 2002, Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone, Proc Natl Acad Sci USA, 99, 8932, 10.1073/pnas.132252399
Stute, 2004, Autologous serum for isolation and expansion of human mesenchymal stem cells for clinical use, Exp Hematol, 32, 1212, 10.1016/j.exphem.2004.09.003
Poloni, 2006, Engraftment capacity of mesenchymal cells following hematopoietic stem cell transplantation in patients receiving reduced-intensity conditioning regimen, Leukemia, 20, 329, 10.1038/sj.leu.2404018
Satake, 2004, Migration of mesenchymal stem cells through cerebrospinal fluid into injured spinal cord tissue, Spine, 29, 1971, 10.1097/01.brs.0000138273.02820.0a
Lange, 2005, Administered mesenchymal stem cells enhance recovery from ischemia/reperfusion-induced acute renal failure in rats, Kidney Int, 68, 1613, 10.1111/j.1523-1755.2005.00573.x
Barry, 2004, Mesenchymal stem cells: clinical applications and biological characterization, Int J Biochem Cell Biol, 36, 568, 10.1016/j.biocel.2003.11.001